Penn Medicine Provider
Hematology, Medical Oncology
Cheryl A. Johnson, MD
4.9
(639)
Accepting new patients
Sees patients age 18 and up
Abramson Cancer Center Kennett Square
View 2 additional locations

About me

Education and training

  • Medical School: Medical College of Pennsylvania
  • Residency: Penn State Milton S. Hershey Medical Center
  • Fellowship: Fox Chase Cancer Center

What my patients think about me

Average Rating
4.9

639 reviews

Comments are submitted by patients and reflect their views and opinions. The comments are not endorsed by and do not necessarily reflect the views of Penn Medicine.

May 2025
5.0
5.0
She is great
April 2025
5.0
5.0
friendly and efficient
April 2025
5.0
5.0
takes time with you
April 2025
5.0
5.0
dr. johnson always takes time to address any questions or concerns i have. i feel like she listens to me and gives me honest answers.

Insurance accepted

My Locations

Penn Medicine hospital privileges

  • Hospital of the University of Pennsylvania: Has privileges to treat patients in the hospital.
  • Penn Presbyterian Medical Center: On the medical staff, but does not have privileges to treat patients in the hospital.
  • Chester County Hospital: Has privileges to treat patients in the hospital.
Dr. Johnson is a Penn Medicine physician.

Qualifications and experience

Treatments and Conditions

My research

Langer CJ, Schaebler D, Sauter E, DeMaria D, Johnson C, Reilly DM, Clark J, Leighton J, Aks C, Litwin S, Ridge JA. Phase II Study of N-phosphonacityl-L-aspartate recombinant interferon-alpha and fluorouracil infusion in advanced squamous cell carcinoma of the head and neck. , Head & Neck, 5: 1998,385-91


Johnson CA, Kilpatrick D, VonRoemeling R, Langer C, Graham MA, Greenslade D, Kennedy G, Keenan E, O'Dwyer PJ. Phase I trial of triapazamine in combination with cisplatin in a single dose every three weeks in patients with solid tumors. , JCO , 2: 1997,773-80


Yao KS, Goodwin AK, Johnson C, O'Dwyer PJ. Alternative splicing and differential expression of DT-diaphorase transcripts in human colon tumors and in peripheral mononuclear cells in response to mitomycin C treatment. , Cancer Research , 8(56): 1996,1731-6